Related Experiment Videos
Renin secretion responsiveness: understanding the efficacy of renin-angiotensin inhibition
H R Brunner1, B Waeber, J Nussberger
1Hypertension Division, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Kidney International. Supplement
|October 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Triple-combination therapy in the treatment of hypertension: a review of the evidence.
Journal of human hypertension·2017
PP125. High mobility group box 1 protein (HMGB1): A pathogenic role in preeclampsia?
Pregnancy hypertension·2015
Physiological response to whole-body vibration in athletes and sedentary subjects.
Physiological research·2014
[Hypertension. Effects of antihypertensive therapy on cognitive functions].
Revue medicale suisse·2013
[Are all diuretics equal for the treatment of hypertensive patients?].
Revue medicale suisse·2012
Effect of kidney disease on glucose handling (including genetic defects).
Kidney international. Supplement·2011
Need for better diabetes treatment for improved renal outcome.
Kidney international. Supplement·2011
Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.
Kidney international. Supplement·2011
SGLT2 inhibitors: molecular design and potential differences in effect.
Kidney international. Supplement·2011
Glucose handling by the kidney.
Kidney international. Supplement·2011
Bone: from a reservoir of minerals to a regulator of energy metabolism.
Kidney international. Supplement·2011
[Retracted] miR‑29a inhibits human retinoblastoma progression by targeting STAT3.
Oncology reports·2026
[Expression of Concern] Gambogic acid inhibits invasion of osteosarcoma via upregulation of TIMP‑1.
International journal of molecular medicine·2026